Development and Characterization of Phytoconstituent Loaded Niosomal Formulation as Targeted Delivery System in Breast Cancer Treatment
DOI:
https://doi.org/10.63682/jns.v14i32S.7600Keywords:
Breast Cancer, Niosomes, Targeted Drug Delivery, Drug Release, Niosomal Formulations, Cancer TherapiesAbstract
The present work aims to comprehensively examine and analyze Niosomal formulations, with a special focus on their potential use as a targeted delivery approach for the treatment of breast cancer. The objective of this study is to get in-depth understanding of the dynamic field of cancer therapeutics by conducting a thorough examination of formulation parameters and characterization techniques. The research aims to address the pressing need for novel treatment options in light of breast cancer's increasing prevalence and impact on women's health in India. This disease has now surpassed cervical cancer as a major cause of morbidity and death among women in the country. Niosomes, which are vesicles composed of lipids, have shown the capacity to augment the sustained release of drugs, so enabling a controlled and prolonged therapeutic effect. By using the mechanism of endocytosis, these formulations effectively promote the internalization of medicines into cellular structures, so permitting precise delivery to specific intracellular locations. The investigation of niosomal formulations as precise delivery methods in the context of breast cancer treatment signifies a notable development in the field of cancer therapies. Niosomes has distinctive characteristics that render them very promising vehicles for drug delivery, since they have the capacity to be customized for precise targeting of cancer cells while minimizing detrimental impacts on healthy organs. Therefore, the use of niosomal formulations as a precise delivery strategy in the treatment of breast cancer has potential in enhancing the therapeutic efficacy of anticancer medications while mitigating undesired adverse reactions. Ongoing scholarly research activities are focused on further investigating and improving these formulations, with the objective of maximizing their efficacy in clinical environments.
Downloads
Metrics
References
Sabarwal, A., Kumar, K., & Singh, R. P. (2018). Hazardous effects of chemical pesticides on human health–Cancer and other associated disorders. Environmental toxicology and pharmacology, 63, 103-114.
Milosevic, M., Jankovic, D., Milenkovic, A., & Stojanov, D. (2018). Early diagnosis and detection of breast cancer. Technology and Health Care, 26(4), 729-759.
Mirza, Z., & Karim, S. (2021, February). Nanoparticles-based drug delivery and gene therapy for breast cancer: Recent advancements and future challenges. In Seminars in cancer biology (Vol. 69, pp. 226-237). Academic Press.
Azer, K., Kaddi, C. D., Barrett, J. S., Bai, J. P., McQuade, S. T., Merrill, N. J., ... & Baliga, N. S. (2021). History and future perspectives on the discipline of quantitative systems pharmacology modeling and its applications. Frontiers in physiology, 12, 637999.
Luo, Y., Tang, W., Xiang, S., Feng, J., & Zu, X. (2022). Non-coding RNAs in breast cancer: Implications for programmed cell death. Cancer Letters, 215929.
Nathanson, S. D., Detmar, M., Padera, T. P., Yates, L. R., Welch, D. R., Beadnell, T. C., & Cheung, K. (2022). Mechanisms of breast cancer metastasis. Clinical & experimental metastasis, 39(1), 117-137.
Sharma, R. (2019). Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990–2016: evidence from Global Burden of Disease Study 2016. Breast Cancer, 26, 428-445.
Kashyap, D., Pal, D., Sharma, R., Garg, V. K., Goel, N., Koundal, D., & Belay, A. (2022). Global increase in breast cancer incidence: risk factors and preventive measures. BioMed research international, 2022.
Bhushan, A., Gonsalves, A., & Menon, J. U. (2021). Current state of breast cancer diagnosis, treatment, and theranostics. Pharmaceutics, 13(5), 723.
Kimmick, G. G., Li, X., Fleming, S. T., Sabatino, S. A., Wilson, J. F., Lipscomb, J., & Wu, X. C. (2018). Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer. Journal of geriatric oncology, 9(3), 214-220.
Cieśla, S., Wichtowski, M., Poźniak-Balicka, R., & Murawa, D. (2021). The surgical anatomy of the mammary gland. Vascularisation, innervation, lymphatic drainage, the structure of the axillary fossa (part 2.). Nowotwory. Journal of Oncology, 71(1), 62-69.
Banerjee, S., Tian, T., Wei, Z., Shih, N., Feldman, M. D., Peck, K. N.,& Robertson, E. S. (2018). Distinct microbial signatures associated with different breast cancer types. Frontiers in microbiology, 9, 951.
Do Nascimento, R. G., & Otoni, K. M. (2020). Histological and molecular classification of breast cancer: what do we know? Mastology, 30, 1-8.
Poirier, É., Desbiens, C., Poirier, B., Boudreau, D., Jacob, S., Lemieux, J., ... & Provencher, L. (2018). Characteristics and long‐term survival of patients diagnosed with pure tubular carcinoma of the breast. Journal of Surgical Oncology, 117(6), 1137-1143.
Zangouri, V., Akrami, M., Tahmasebi, S., Talei, A., & Hesarooeih, A. G. (2018). Medullary breast carcinoma and invasive ductal carcinoma: a review study. Iranian Journal of Medical Sciences, 43(4), 365.
Sun, P., Zhong, Z., Lu, Q., Li, M., Chao, X., Chen, D.,& He, J. (2020). Mucinous carcinoma with micropapillary features is morphologically, clinically and genetically distinct from pure mucinous carcinoma of breast. Modern Pathology, 33(10), 1945-1960.
Kulka, J., Madaras, L., Floris, G., & Lax, S. F. (2022). Papillary lesions of the breast. Virchows Archiv, 1-20.
Demir, S., Sezgin, G., Sari, A. A., Kucukzeybek, B. B., Yigit, S., Etit, D., & Kucukzeybek, Y. (2021). Clinicopathological analysis of invasive cribriform carcinoma of the breast, with review of the literature. Annals of Diagnostic Pathology, 54, 151794.
Ogata, H., Mitsuzuka, Y., Honma, N., Yoshida, M., Sumazaki, M., Saito, F., & Kaneko, H. (2018). Sonographic visualization of nipple blood flow can help differentiate Paget disease from benign eczematous nipple lesions. PLoS One, 13(5), e0197156.
Rayzah, M. (2020). Phyllodes tumors of the breast: a literature review. Cureus, 12(9).
Gucalp, A., Traina, T. A., Eisner, J. R., Parker, J. S., Selitsky, S. R., Park, B. H., ... & Cardoso, F. (2019). Male breast cancer: a disease distinct from female breast cancer. Breast cancer research and treatment, 173, 37-48.
Bertucci, F., Ng, C. K., Patsouris, A., Droin, N., Piscuoglio, S., Carbuccia, N., & André, F. (2019). Genomic characterization of metastatic breast cancers. Nature, 569(7757), 560-564.
Kaur, D., & Kumar, S. (2018). Niosomes: present scenario and future aspects. Journal of drug delivery and therapeutics, 8(5), 35-43.
Umbarkar, M. G. (2021). Niosome as a Novel Pharmaceutical Drug Delivery: A Brief Review Highlighting Formulation, Types, Composition and Application. Indian Journal of Pharmaceutical Education & Research, 55.
Ahmadi, S., Seraj, M., Chiani, M., Hosseini, S., Bazzazan, S., Akbarzadeh, I., & Mostafavi, E. (2022). In vitro development of controlled-release nanoNiosomesfor improved delivery and anticancer activity of letrozole for breast cancer treatment. International Journal of Nanomedicine, 6233-6255.
Ananthalakshmi, A. (2022). Formulation and Evaluation of Alpinia Galanga Extract Loaded Niosomal Patch for the Treatment of Breast Cancer (Doctoral dissertation, College of Pharmacy, Madras Medical College, Chennai).
Kyriakoudi, A., Spanidi, E., Mourtzinos, I., & Gardikis, K. (2021). Innovative delivery systems loaded with plant bioactive ingredients: Formulation approaches and applications. Plants, 10(6), 1238.
Raj, S., Khurana, S., Choudhari, R., Kesari, K. K., Kamal, M. A., Garg, N., & Kumar, D. (2021, February). Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy. In Seminars in cancer biology (Vol. 69, pp. 166-177). Academic Press.
Raj, S., Khurana, S., Choudhari, R., Kesari, K. K., Kamal, M. A., Garg, N., & Kumar, D. (2021, February). Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy. In Seminars in cancer biology (Vol. 69, pp. 166-177). Academic Press.
Sharma, A., & Malairaman, U. (2020). Development of Targeted Drug Delivery System for Breast Cancer (Doctoral dissertation, Jaypee University of Information Technology, Solan, HP).
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
